The Australian government is reviewing 50 recommendations for reforming the country’s health technology assessment (HTA) system, one of which involves setting up a “bridging funding program” to provide early, temporary subsidized access to certain promising, time-critical therapies.
Key Takeaways
-
A 236-page report on the most comprehensive review of Australia’s HTA system in over 30 years has provided 50 recommendations for improvements for the government to consider.
-
One of the recommendations suggests establishing a bridging funding program for therapies of high added therapeutic value that address high unmet clinical need.
-
The report says that the government should also support a reduction of the base case discount rate to no lower than 3
The government should also design a framework that supports the use of different contract and health technology funding mechanisms in addition to the standard “price per unit” approach, and consider exempting
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?